原发性骨质疏松症诊治指南(2011年)

[1] 临床诊疗指南[M]. 人民卫生出版社 , 中华医学会编著, 2006

[2] Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials[J] . H A Bischoff-Ferrari,B Dawson-Hughes,H B Staehelin,J E Orav,A E Stuck,R Theiler,J B Wong,A Egli,D P Kiel,J Henschkowski.BMJ: British Medical Journal . 2009 (7725)

[3] Long-term treatment of postmenopausal osteoporosis with strontium ranelate: Results at 8 years[J] . J.Y. Reginster,O. Bruyère,A. Sawicki,A. Roces-Varela,P. Fardellone,A. Roberts,J.P. Devogelaer.Bone . 2009 (6)

[4] European guidance for the diagnosis and management of osteoporosis in postmenopausal women [J]. OSTEOPOROSIS INTERNATIONAL, 2008, 19 (04) : 399 - 428

[5] Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (18): : 1809 - 1822

[6] Need for Additional Calcium to Reduce the Risk of Hip Fracture with Vitamin D Supplementation: Evidence from a Comparative Metaanalysis of Randomized Controlled Trials[J] . Steven Boonen,Paul Lips,Roger Bouillon,Heike A. Bischoff-Ferrari,Dirk Vanderschueren,Patrick Haentjens.The Journal of Clinical Endocrinology & Metabolism . 2007 (4)

[7] Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study[J] . J Y. Reginster,E Seeman,M C. De Vernejoul,S Adami,J Compston,C Phenekos,J P. Devogelaer,M Diaz Curiel,A Sawicki,S Goemaere,O H. Sorensen,D Felsenberg,P J. Meunier.The Journal of Clinical Endocrinology & Metabolism . 2005 (5)

[8] Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study[J] . P. D. Delmas,R. R. Recker,C. H. Chesnut,A. Skag,J. A. Stakkestad,R. Emkey,J. Gilbride,R. C. Schimmer,C. Christiansen.Osteoporosis International . 2004 (10)

[9] Efficacy and safety of raloxifene 60 milligrams/day in postmenopausal Asian women [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07): : 3130 - 3136

[10] Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial[J] . Pierre D. Delmas,Kristine E. Ensrud,Jonathan D. Adachi,Kristine D. Harper,Somnath Sarkar,Carlo Gennari,Jean-Yves Reginster,Huibert A. P. Pols,Robert R. Recker,Steven T. Harris,Wentao Wu,Harry K. Genant,Dennis M. Black,Richard Eastell.The Journal of Clinical Endocrinology & Metabolism . 2002 (8)

[1] 临床诊疗指南[M]. 人民卫生出版社 , 中华医学会编著, 2006

[2] Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials[J] . H A Bischoff-Ferrari,B Dawson-Hughes,H B Staehelin,J E Orav,A E Stuck,R Theiler,J B Wong,A Egli,D P Kiel,J Henschkowski.BMJ: British Medical Journal . 2009 (7725)

[3] Long-term treatment of postmenopausal osteoporosis with strontium ranelate: Results at 8 years[J] . J.Y. Reginster,O. Bruyère,A. Sawicki,A. Roces-Varela,P. Fardellone,A. Roberts,J.P. Devogelaer.Bone . 2009 (6)

[4] European guidance for the diagnosis and management of osteoporosis in postmenopausal women [J]. OSTEOPOROSIS INTERNATIONAL, 2008, 19 (04) : 399 - 428

[5] Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (18): : 1809 - 1822

[6] Need for Additional Calcium to Reduce the Risk of Hip Fracture with Vitamin D Supplementation: Evidence from a Comparative Metaanalysis of Randomized Controlled Trials[J] . Steven Boonen,Paul Lips,Roger Bouillon,Heike A. Bischoff-Ferrari,Dirk Vanderschueren,Patrick Haentjens.The Journal of Clinical Endocrinology & Metabolism . 2007 (4)

[7] Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study[J] . J Y. Reginster,E Seeman,M C. De Vernejoul,S Adami,J Compston,C Phenekos,J P. Devogelaer,M Diaz Curiel,A Sawicki,S Goemaere,O H. Sorensen,D Felsenberg,P J. Meunier.The Journal of Clinical Endocrinology & Metabolism . 2005 (5)

[8] Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study[J] . P. D. Delmas,R. R. Recker,C. H. Chesnut,A. Skag,J. A. Stakkestad,R. Emkey,J. Gilbride,R. C. Schimmer,C. Christiansen.Osteoporosis International . 2004 (10)

[9] Efficacy and safety of raloxifene 60 milligrams/day in postmenopausal Asian women [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07): : 3130 - 3136

[10] Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial[J] . Pierre D. Delmas,Kristine E. Ensrud,Jonathan D. Adachi,Kristine D. Harper,Somnath Sarkar,Carlo Gennari,Jean-Yves Reginster,Huibert A. P. Pols,Robert R. Recker,Steven T. Harris,Wentao Wu,Harry K. Genant,Dennis M. Black,Richard Eastell.The Journal of Clinical Endocrinology & Metabolism . 2002 (8)